BIOMAT Database Logo BIOMAT Database Logo

[Efficacy of influenza prophylaxis with inactivated vaccines]. 1983

A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D008887 Military Medicine The practice of medicine as applied to special circumstances associated with military operations. Medicine, Military
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014586 USSR A country located from the Baltic and Black seas to the Pacific Ocean and, for a time including 15 Soviet Socialist Republics. The capital was Moscow. Soviet Union,Union of Soviet Socialist Republics
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Efficacy of inactivated influenza vaccines in young children.
May 2018, The Lancet. Child & adolescent health,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
[Inactivated influenza vaccines].
January 1978, Voprosy virusologii,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Safety and efficacy of inactivated influenza vaccines in children.
February 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Comparative efficacy of inactivated and live attenuated influenza vaccines.
September 2009, The New England journal of medicine,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.
January 1969, Bulletin of the World Health Organization,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Editorial: Inactivated influenza vaccines.
December 1973, The New England journal of medicine,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.
March 2007, Virology,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines.
May 2003, Vaccine,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Seasonal inactivated influenza virus vaccines.
September 2008, Vaccine,
A V Slobodeniuk, and Iu I Vaserin, and V A Kramarevskiĭ, and V B Filimonov, and Iu P Glotov
Inactivated and adjuvanted influenza vaccines.
January 2015, Current topics in microbiology and immunology,
Copied contents to your clipboard!